In recent years, more and more multinational pharmaceutical executives and overseas talents have focused on innovative pharmaceutical companies
in China.
According to incomplete statistics, a total of 12 domestic-funded pharmaceutical companies introduced overseas high-end talents
in 2021, including Hengrui Pharmaceutical, BeiGene, Junshi Biologics, and Corning Jereh.
Among them, 6 chief medical officers were appointed; 1 Chief Financial Officer, 1 Development Officer and 1 Operations Officer; 1 person in charge of business development; and 2 at the level of vice president and president
.
Since 2022, the trend of senior executives from multinational pharmaceutical companies flowing to local innovative pharmaceutical companies has continued
.
Recently, Sihe Gene released news announcing that Huang Yue, former head of translational medicine at Merck China, officially joined Sihe Genomics as the Chief Translational Science Officer (CTO), fully responsible for the preclinical and clinical research and development of
Sihe Gene's independent innovation antisense oligonucleic acid drug research and development project.
According to the data, Sihe Gene is a biotechnology company established just last year, focusing on antisense oligonucleic acid technology, and currently has a number of pipelines for metabolism, tumor, central nervous system diseases and so on
.
It is understood that these areas are what Huang Yue is good at, and he has 22 years of experience in R&D management of
innovative drug business.
From 2020 to 2021, he served as the executive director of Simcere Pharmaceutical and the head of planning and construction of Beijing Translational Science Platform, managing the clinical phase III implementation and progress
of the innovative drug pipeline.
Prior to that, Yue Huang also worked at Merck Serano for about 5 years as Global Head of Translational Medicine/Global Head of Early Development, responsible for the decision-making promotion of the global pipeline China project and external BD cooperation decision support
.
In fact, in recent years, there have been many cases of multinational pharmaceutical executives flowing to local innovative pharmaceutical companies
.
On April 1, Zhou You, former Chief Marketing Officer of Sanofi China, assumed the post of CStone Pharmaceutical, serving as the general manager of Greater China and the head of the company's commercial department, responsible for product commercialization
.
On March 31, Wu Kun, former Head of Pfizer Biopharma Group China and Head of Pfizer Innovative Healthcare China, assumed the position of Chief Commercial Officer of Jinxing Pharmaceutical, responsible for formulating Minzer's commercialization strategy and building a superior marketing team to drive the commercialization of
the company's growing product portfolio.
On March 28, Simcere announced the appointment of Danny Chen, former Senior Vice President of SciNeuro, as Senior Vice President of the Group, responsible for promoting the company's R&D work in the field of translational science and neuroscience, as well as the formation and management of the R&D team of Beijing Innovation Center, to enhance Simcere's global R&D capabilities
in the field of central nervous system therapy.
In mid-March, Zai Lab also announced the appointment of Josh Smiley, who had been responsible for finance, corporate strategy, business development, venture capital and global business services operations at Eli Lilly, as chief operating officer; Simcere Pharmaceuticals announced the appointment of Danny Chen, former Senior Vice President of SciNeuro, as Group Senior Vice President
.
.
.
.
.
.
.
In fact, the executive changes of multinational pharmaceutical companies have not only begun in the past two years, and many high-ranking leadership figures have frequently left since 2018 and chosen to join innovative pharmaceutical companies to start a new life
.
This operation shows from the side that local innovative pharmaceutical companies are rising, attracting more senior management talents in the pharmaceutical industry to join
.
At the same time, the demand for high-level talents by local innovative pharmaceutical companies is also increasing
.
However, it should be noted that there are also certain challenges
when the talent flow of multinational pharmaceutical companies to local pharmaceutical companies to help enterprises develop.
For example, the number of executives of multinational pharmaceutical companies working for local pharmaceutical companies and then leaving is also increasing
.
Previously, Merck announced that Luo Wanli will return to Merck to be responsible for Merck's Human Health International Department and join the company's executive committee.
In addition, Roche also announced earlier that from February 22, 2022, Mr.
Qian Wei will be appointed as the general manager of the oncology field of Roche Pharma China's customer interaction business model, responsible for the work
of Roche oncology.
This is also Qian Wei's return
after leaving Roche at the end of June 2021.
Analysts believe that with the transformation of the pharmaceutical market and the rapid development of the domestic innovative pharmaceutical industry, the executives of multinational pharmaceutical companies are constantly flowing to local innovative pharmaceutical companies
.
However, it should be noted that the talent market of pharmaceutical companies is full of uncertainty
.
Therefore, for local pharmaceutical companies, rather than hiring high-paid executives, they should re-examine the competitive situation of the entire jungle and return to the value of drugs itself
after the shock adjustment.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"Share to:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
